{"id":"W1998311214","doi":"10.1016/j.urolonc.2004.11.008","title":"A Phase II study of oxaliplatin in urothelial cancer","year":2005,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Oxaliplatin; Medicine; Cisplatin; Nausea; Internal medicine; Chemotherapy; Phases of clinical research; Oncology; Toxicity; Clinical endpoint; Urology; Cancer; Surgery; Clinical trial; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003798919,0.001932654,0.004485613,0.0009087421,0.0008264194,0.001733157,0.001470771,0.002328847,0.003483446],"category_scores_gemma":[0.001802847,0.001112054,0.002602628,0.0008614764,0.001986616,0.0014575,0.00060332,0.004521945,0.000788592],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001313164,"about_ca_system_score_gemma":0.00269486,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002484261,"about_ca_topic_score_gemma":0.003165507,"domain_scores_codex":[0.9986705,0.0007217797,0.00006132852,0.0001923677,0.00008015386,0.0002740333],"domain_scores_gemma":[0.998168,0.0003944889,0.0002607158,0.0002441618,0.0001139237,0.0008187329],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8717867,0.06789397,0.002490942,0.0005900049,0.001023434,0.0001541492,0.0002979152,0.001347968,0.01576377,0.0001909157,0.00138068,0.03707953],"study_design_scores_gemma":[0.72536,0.2685193,0.002892132,0.00001492534,0.0003380841,0.00007663958,0.00005169113,0.0003023666,0.001445604,0.00009433511,0.0008862488,0.00001864823],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908559,0.00279122,0.0007130756,0.0005535004,0.0002503297,0.002920127,0.0006891325,0.00006166966,0.001165139],"genre_scores_gemma":[0.986558,0.003028745,0.001630898,0.001054461,0.0003394563,0.002422651,0.001709324,0.0000481365,0.003208326],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004485613,"threshold_uncertainty_score":0.02009082,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04288365957811869,"score_gpt":0.3768328459018545,"score_spread":0.3339491863237358,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}